✦ LIBER ✦

Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis

✍ Scribed by S. NISHIMURA; H. TSUDA; Y. HASHIGUCHI; K. KOKAWA; R. NISHIMURA; O. ISHIKO; S. KAMIURA; K. HASEGAWA; N. UMESAKI

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly irinotecan and

✍ Takiguchi, Yuichi; Moriya, Tetsuro; Asaka-Amano, Yoshiko; Kawashima, Tatsuo; Kur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Cisplatin plus gemcitabine in platinum-r

✍ Cheryl A. Brewer; John A. Blessing; Robert A. Nagourney; Mark Morgan; Parviz Han 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

5029 POSTER Early termination of a phase

✍ Petru, E.; Angleitner-Boubenizek, L.; Reinthaller, A.; Volgger, B.; Kohlberger, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A phase II clinical trial of pegylated l

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

A phase II evaluation of tirapazamine pl

✍ Allan Covens; John Blessing; David Bender; Robert Mannel; Mark Morgan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A phase II study of GM-CSF and rIFN-γ1b

✍ Kathleen M. Schmeler; Saroj Vadhan-Raj; Pedro T. Ramirez; Sachin M. Apte; Lorenz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 402 KB